Literature DB >> 8995648

Effect of a modulator deletion on transcription of the human cytomegalovirus major immediate-early genes in infected undifferentiated and differentiated cells.

J L Meier1, M F Stinski.   

Abstract

Differentiation-dependent expression of the human cytomegalovirus (HCMV) major immediate-early (MIE) genes, encoding IE1 and IE2, may partly govern virus replication in monocytic THP-1 and embryonal carcinoma (Tera-2) cells. The modulator of the MIE promoter was shown previously in transient transfection assays to repress transcription from promoter segments in undifferentiated THP-1 and Tera-2 cells but not in differentiated cells. To determine the biological importance of these findings, we constructed a recombinant HCMV (r delta MSVgpt) without a modulator. In comparison to wild-type (WT) virus, r delta MSVgpt exhibits a slight delay in growth in human fibroblasts, but there is no appreciable change in IE1 and IE2 transcription. Moreover, there is no appreciable change in the early/late kinetics of transcription of RNAs colinear with the predicted UL128 coding region, which is adjacent to the modulator, although the size distribution and abundance of these RNAs are altered. In infected undifferentiated THP-1 and Tera-2 cells, WT and r alpha MSVgpt viruses produce minimal but comparable amounts of IE1 RNAs. The genomes of both viruses are detectable in similar amounts within these undifferentiated cells. Induction of cellular differentiation before infection overcomes the block in MIE gene transcription. WT and r alpha MSVgpt infections of differentiated THP-1 cells produce similar levels of IE1 and IE2 RNAs. Thus, differentiation-dependent control of MIE gene transcription involves regulatory mechanisms other than the modulator. Possible alternative functions of the modulator are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 8995648      PMCID: PMC191179     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

1.  An improved T1/A ribonuclease protection assay.

Authors:  M Bordonaro; C F Saccomanno; J L Nordstrom
Journal:  Biotechniques       Date:  1994-03       Impact factor: 1.993

2.  Cytomegalovirus infection of human teratocarcinoma cells in culture.

Authors:  E Gönczöl; P W Andrews; S A Plotkin
Journal:  J Gen Virol       Date:  1985-03       Impact factor: 3.891

3.  Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient.

Authors:  C A Wiley; R D Schrier; F J Denaro; J A Nelson; P W Lampert; M B Oldstone
Journal:  J Neuropathol Exp Neurol       Date:  1986-03       Impact factor: 3.685

4.  Definition of a subset of human peripheral blood mononuclear cells that are permissive to human cytomegalovirus infection.

Authors:  C Söderberg; S Larsson; S Bergstedt-Lindqvist; E Möller
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

5.  Release of human immunodeficiency virus by THP-1 cells and human macrophages is regulated by cellular adherence and activation.

Authors:  R J Shattock; J S Friedland; G E Griffin
Journal:  J Virol       Date:  1993-06       Impact factor: 5.103

6.  Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells.

Authors:  E Gönczöl; P W Andrews; S A Plotkin
Journal:  Science       Date:  1984-04-13       Impact factor: 47.728

7.  Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication.

Authors:  G S Pari; D G Anders
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Varicella-zoster virus transcription in human trigeminal ganglia.

Authors:  J L Meier; R P Holman; K D Croen; J E Smialek; S E Straus
Journal:  Virology       Date:  1993-03       Impact factor: 3.616

9.  Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells.

Authors:  J Stein; H D Volk; C Liebenthal; D H Krüger; S Prösch
Journal:  J Gen Virol       Date:  1993-11       Impact factor: 3.891

10.  Induction of endogenous human cytomegalovirus gene expression after differentiation of monocytes from healthy carriers.

Authors:  J Taylor-Wiedeman; P Sissons; J Sinclair
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

View more
  53 in total

1.  A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer.

Authors:  C A Lundquist; J L Meier; M F Stinski
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter.

Authors:  A Angulo; D Kerry; H Huang; E M Borst; A Razinsky; J Wu; U Hobom; M Messerle; P Ghazal
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  Role of regulatory elements and the MAPK/ERK or p38 MAPK pathways for activation of human cytomegalovirus gene expression.

Authors:  Jiping Chen; Mark F Stinski
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection.

Authors:  Hiroki Isomura; Mark F Stinski
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  Activation of transcription of the human cytomegalovirus early UL4 promoter by the Ets transcription factor binding element.

Authors:  J Chen; M F Stinski
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

6.  Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication.

Authors:  Hiroki Isomura; Tatsuya Tsurumi; Mark F Stinski
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Phorbol ester-induced human cytomegalovirus major immediate-early (MIE) enhancer activation through PKC-delta, CREB, and NF-kappaB desilences MIE gene expression in quiescently infected human pluripotent NTera2 cells.

Authors:  Xiaoqiu Liu; Jinxiang Yuan; Allen W Wu; Patrick W McGonagill; Courtney S Galle; Jeffery L Meier
Journal:  J Virol       Date:  2010-05-26       Impact factor: 5.103

8.  Development of a high-throughput assay to measure the neutralization capability of anti-cytomegalovirus antibodies.

Authors:  Thomas J Gardner; Cynthia Bolovan-Fritts; Melissa W Teng; Veronika Redmann; Thomas A Kraus; Rhoda Sperling; Thomas Moran; William Britt; Leor S Weinberger; Domenico Tortorella
Journal:  Clin Vaccine Immunol       Date:  2013-02-06

9.  A cis element between the TATA Box and the transcription start site of the major immediate-early promoter of human cytomegalovirus determines efficiency of viral replication.

Authors:  Hiroki Isomura; Mark F Stinski; Ayumi Kudoh; Sanae Nakayama; Takayuki Murata; Yoshitaka Sato; Satoko Iwahori; Tatsuya Tsurumi
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

10.  Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.

Authors:  Yuying Liang; Don Ganem
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.